Access to critical pharmaceuticals at the lowest net cost for patients remains an essential objective that drives the American healthcare system. PBMs play a significant role in this equation, negotiating with manufacturers and navigating the complexities of drug pricing to achieve the best possible offers. However, the market’s dynamic character, combined with developing rebate structures, requires some deviation from typical data management and reporting approaches. Xevant, a revolutionary pharmaceutical analytics platform, addresses this issue, providing a full suite of must-have analytics solutions that equip PBMs with the tools they need to achieve maximum cost reductions and transparency for their clients.

Leave a Reply

Your email address will not be published. Required fields are marked *